SCHEMBL25522432

SCHEMBL25522432

CC(C)c1c(O)cc(-c2ccc3c(N)ccnc3c2)cc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 2/20 0.45
▸ SOS2 Q07890 1/20 0.45
▸ NCF1 P14598 1/20 0.39
▸ TLR8 Q9NR97 7/20 0.37
▸ CYP3A4 P08684 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ EGFR P00533 2/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ HCK P08631 1/20 0.35
▸ SRC P12931 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ EPHB4 P54760 1/20 0.35
▸ PRKDC P78527 1/20 0.35
▸ TLR7 Q9NYK1 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25522342 0.91 NR4A2 (0.40) NR4A2SOS2NCF1TLR8CYP3A4
SCHEMBL25520064 0.84 TLR8 (0.44) TLR8HSD17B10EGFRTLR7TLR9
SCHEMBL25521679 0.79 TLR9 (0.41) TLR8HSD17B10EGFRPIK3CDABL1
SCHEMBL25522336 0.76 TLR8 (0.40) TLR8EGFRRIPK2TGFBR1
SCHEMBL25521410 0.75 RAF1 (0.41) TLR8PIK3CATLR7TLR9
SCHEMBL23430687 0.73 NR4A2 (0.56) NR4A2SOS2NCF1ALKSYK
SCHEMBL25523476 0.73 MAPKAPK2 (0.46) KDRRIPK2
SCHEMBL15138972 0.72 NCF1 (0.58) NR4A2SOS2NCF1ALOX15HSD17B10
SCHEMBL12545963 0.72 NR4A2 (0.56) NR4A2SOS2NCF1ALOX15HSD17B10
SCHEMBL25521671 0.72 MAP4K4 (0.58) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086428-A2 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2023-05-19 — — WO disclosed
Send feedback